Evaluation of the clinical outcome of nab-paclitaxel on multiple primary malignancies: a systematic review and meta-analysis
F Salehi Kahrizsangi, N Mehrafar… - … in Dental and …, 2022 - archives.articleproms.com
… been made to analyze the side effects of nab-paclitaxel compared to sb-paclitaxel and
docetaxel. The present study aimed to evaluate the clinical outcome of Nab-paclitaxel on Multiple …
docetaxel. The present study aimed to evaluate the clinical outcome of Nab-paclitaxel on Multiple …
Does nab-paclitaxel have a higher incidence of peripheral neuropathy than solvent-based paclitaxel? Evidence from a systematic review and meta-analysis
X Guo, H Sun, J Dong, Y Feng, H Li, R Zhuang… - Critical Reviews in …, 2019 - Elsevier
… nab-paclitaxel and solvent-based paclitaxel mono-chemotherapy. In total, 24 articles were
included in this meta-analysis… by nab-paclitaxel was higher than solvent-based paclitaxel. The …
included in this meta-analysis… by nab-paclitaxel was higher than solvent-based paclitaxel. The …
[HTML][HTML] Comparison between nab-paclitaxel and solvent-based taxanes as neoadjuvant therapy in breast cancer: a systematic review and meta-analysis
M Liu, S Liu, L Yang, S Wang - BMC cancer, 2021 - Springer
… nab- or sb-paclitaxel were standard therapies supported by guidelines [2,3,4]. In the present
meta-analysis, nab-paclitaxel … is supported by the previous meta-analysis by Zong et al. [14]. …
meta-analysis, nab-paclitaxel … is supported by the previous meta-analysis by Zong et al. [14]. …
Incidence and risk of peripheral neuropathy with nab‐paclitaxel in patients with cancer: a meta‐analysis
L Peng, Z Bu, X Ye, Y Zhou… - European journal of cancer …, 2017 - Wiley Online Library
… neuropathy associated with nab-paclitaxel. The present meta-analysis has combined 19 …
Our meta-analysis results demonstrated that nab-paclitaxel is associated with an increased …
Our meta-analysis results demonstrated that nab-paclitaxel is associated with an increased …
[HTML][HTML] Role of nab-paclitaxel in metastatic breast cancer: a meta-analysis of randomized clinical trials
Y Liu, G Ye, D Yan, L Zhang, F Fan, J Feng - Oncotarget, 2017 - ncbi.nlm.nih.gov
… In conclusion, the current meta-analysis failed to demonstrate superiority of nab-paclitaxel
to sb-paclitaxel and docetaxel in patients with MBC. The newer agent was associated with …
to sb-paclitaxel and docetaxel in patients with MBC. The newer agent was associated with …
[HTML][HTML] A systematic review and meta-analysis of nab-paclitaxel mono-chemotherapy for metastatic breast cancer
H Lu, S Zha, W Zhang, Q Wang, D Jiang, X Xu… - BMC cancer, 2021 - Springer
… In this systematic review and meta-analysis, we demonstrated that nab-paclitaxel mono-chemotherapy
was a low-toxicity and effective strategy in the palliative management of MBC …
was a low-toxicity and effective strategy in the palliative management of MBC …
[HTML][HTML] Nab-paclitaxel plus gemcitabine as first-line treatment for advanced pancreatic cancer: a systematic review and meta-analysis
Y Zhang, J Xu, J Hua, J Liu, C Liang, Q Meng… - Journal of …, 2019 - ncbi.nlm.nih.gov
… of nab-paclitaxel plus gemcitabine (NG) as a first-line treatment for advanced pancreatic cancer.
A meta-analysis was … This analysis further demonstrates the efficacy and safety of NG for …
A meta-analysis was … This analysis further demonstrates the efficacy and safety of NG for …
[HTML][HTML] Efficacy and safety of nab-paclitaxel plus platinum in non-small cell lung cancer: a meta-analysis
T Tan, S Li, W Hu, T Yue, Q Zeng, X Zeng… - Frontiers in …, 2023 - frontiersin.org
… The results of the meta-analysis indicated evidence of higher ORR after nab-P + C/Cis … in
combination with conventional chemotherapy agents or traditional paclitaxel (Figure 3), with …
combination with conventional chemotherapy agents or traditional paclitaxel (Figure 3), with …
Is nab-paclitaxel better than conventional taxanes as neoadjuvant therapy for breast cancer? A meta-analysis
Y Li, X Lu, Q Lin, W Li - Journal of International Medical …, 2020 - journals.sagepub.com
… This meta-analysis implied that nab-paclitaxel more effectively improved pCR than … who
might benefit from nab-paclitaxel, our meta-analysis clearly indicated that nab-paclitaxel is more …
might benefit from nab-paclitaxel, our meta-analysis clearly indicated that nab-paclitaxel is more …
[HTML][HTML] … of gemcitabine plus nab-paclitaxel and FOLFIRINOX in the first-line setting of metastatic pancreatic cancer: a systematic review and meta-analysis
S Pusceddu, M Ghidini, M Torchio, F Corti… - Cancers, 2019 - mdpi.com
… Gemcitabine and nab-paclitaxel (GEM-NAB) and the combination of 5-fluorouracil, oxaliplatin,
… This meta-analysis aims to compare GEM-NAB and FOLFIRINOX in terms of safety and …
… This meta-analysis aims to compare GEM-NAB and FOLFIRINOX in terms of safety and …
相关搜索
- role of nab paclitaxel meta analysis
- safety of nab paclitaxel meta analysis
- breast cancer nab paclitaxel
- systematic review meta analysis
- metastatic pancreatic cancer nab paclitaxel
- cell lung cancer nab paclitaxel
- nab paclitaxel monotherapy
- prognostic factors nab paclitaxel
- solvent based paclitaxel meta analysis
- weekly nab paclitaxel
- neoadjuvant chemotherapy meta analysis
- comparative effectiveness nab paclitaxel
- peripheral neuropathy meta analysis
- nab paclitaxel plus gemcitabine
- first line chemotherapy nab paclitaxel
- retrospective analysis nab paclitaxel